Analysis of sphingolipids in extracted human plasma using liquid chromatography electrospray ionization tandem mass spectrometry

Analytical Biochemistry

Volumn 423, Issue 2, 2012, Pages 187-194

  Bui, Hai H ^a   Leohr, Jennifer K ^a   Kuo, Ming Shang ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Human plasma; Mass spectrometry; Sphingolipids

Indexed keywords

DICHLOROMETHANE; ELECTROSPRAY IONIZATION; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLITES; PLASMA (HUMAN); SCREENING;

CORRELATION COEFFICIENT; HUMAN PLASMAS; LIQUID CHROMATOGRAPHY ELECTROSPRAY; MASS SPECTROMETRIC ANALYSIS; MEDIUM-THROUGHPUT SCREENING; MULTIPLE-REACTION MONITORING MODES; SAMPLE PREPARATION METHODS; SPHINGOLIPIDS;

EXTRACTION;

CERAMIDE; CERAMIDE HEXOSIDE; DIHYDROCERAMIDE; GANGLIOSIDE GM3; GLUCOSYLCERAMIDE; SPHINGOLIPID; SPHINGOSINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; ELECTROSPRAY MASS SPECTROMETRY; EXTRACTION; FEMALE; HUMAN; LIPID ANALYSIS; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; METABOLITE; NORMAL HUMAN; PLASMA; PRIORITY JOURNAL; SEX DIFFERENCE; TANDEM MASS SPECTROMETRY;

EID: 84857965778     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2012.01.027     Document Type: Article

References (52)

1. Y. Chen, Y. Liu, M.C. Sullards, A.H. Merrill Jr., An introduction of sphingolipid metabolism and analysis by new technologies, Neuromol. Med. 12 (2010) 306-319.
2. A.H. Merrill Jr., De novo sphingolipid biosynthesis: a necessary but dangerous pathway, J. Biol. Chem. 277 (2002) 25843-25846. (Pubitemid 34967059)
3. Y.A. Hannun, L.M. Obeid, The ceramide-centric universe of lipid-mediated cell regulation: Stress encounters of the lipid kind, J. Biol. Chem. 277 (2002) 25847-25850. (Pubitemid 34967060)
4. S. Spiegel, S. Milstien, Sphingosine-1-phosphate: An enigmatic signaling lipid, Nat. Rev. Mol. Cell Biol. 4 (2003) 397-407.
5. Y.A. Hannun, C. Luberto, Ceramide in the eukaryotic stress response, Trends Cell Biol. 10 (2000) 73-80. (Pubitemid 30084778)
6. Y.Z. Zhang, R. Kolesnick, Signaling through the sphingomyelin pathway, Endocrinology 136 (1995) 4157-4160.
7. Y.A. Hannun, R.M. Bell, Functions of sphingolipids and sphingolipid breakdown products in cellular regulation, Science 243 (1989) 500-507. (Pubitemid 19048748)
8. T.A. Taha, T.D. Mullen, L.M. Obeid, A house divided: ceramide, sphingosine, and sphingosine-1-phosphate in programmed cell death, Biochim. Biophys. Acta 1758 (2006) 2027-2036. (Pubitemid 44879375)
9. J.M. Jacob, S.R. Kashyap, T. Kasumov, R. Zhang, K.R. Kelly, R.A. DeFronzo, J.P. Kirwan, Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance, Diabetes 58 (2009) 337-354.
10. W.L. Holland, S.A. Summers, Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism, Endocr. Rev. 29 (2008) 381-402. (Pubitemid 351831506)
11. F. Samad, K.D. Hester, G. Yang, Y.A. Hannun, J. Bielawski, Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk, Diabetes 55 (2006) 2579-2587. (Pubitemid 44871159)
12. H. Huang, T. Kasumov, P. Gatmaitan, H.M. Heneghan, S.R. Kashyap, P.R. Schauer, S.A. Brethauer, J.P. Kirwan, Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients, Obesity 19 (2011) 2235-2240.
13. I. Ichi, K. Nakahara, Y. Miyashita, A. Hidaka, S. Kutsukake, K. Inoue, T. Maruyama, Y. Miwa, M. Harada-Shiba, M. Tsushima, S. Kojo, For Kisei Cohort Study Group, Association of ceramides in human plasma with risk factors of atherosclerosis, Lipids 41 (2006) 859-863. (Pubitemid 44788907)
14. J. Bismuth, P. Lin, Q. Yao, C. Chen, Ceramide: a common pathway for atherosclerosis, Atherosclerosis 196 (2008) 497-504.
15. J.M. Aerts, R. Ottenhoff, A.S. Powlson, A. Grefhorst, M. van Eijk, P.F. Dubbelhuis, J. Aten, F. Kuipers, M.J. Serlie, T. Wennekes, J.K. Sethi, S. O'Rahilly, H.S. Overkleeft, Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity, Diabetes 56 (2007) 1341-1349. (Pubitemid 46715620)
16. H. Zhao, M. Przybylska, I-H. Wu, J. Zhang, C. Siegel, S. Komarnitsky, N.S. Yew, S.H. Cheng, Inhibiting glycosphingolipid synthesis improves glycemic control and insulin sensitivity in animal models of type 2 diabetes, Diabetes 56 (2007) 1210-1218. (Pubitemid 46715599)
17. T. Yamashita, A. Hashiramoto, M. Haluzik, H. Mizukami, S. Beck, A. Norton, M. Kono, S. Tsuji, J.L. Daniotti, N. Werth, R. Sandhoff, K. Sandhoff, R.L. Proia, Enhanced insulin sensitivity in mice lacking ganglioside GM3, Proc. Natl. Acad. Sci. USA 100 (2003) 3445-3449. (Pubitemid 36356603)
18. T. Sato, Y. Nihei, M. Nagafuku, S. Tagami, R. Chin, M. Kawamura, S. Miyazaki, M. Suzuki, S-I. Sugahara, Y. Takahashi, A. Saito, Y. Igarashi, J-I. Inokuchi, Circulating levels of ganglioside GM3 in metabolic syndrome: A pilot study, Obesity Res. Clin. Pract. 2 (2008) 231-238.
19. W.L. Holland, T.A. Knotts, J.A. Chavez, L-P. Wang, K.L. Hoeln, S.A. Summers, Lipid mediators of insulin resistance, Nutr. Rev. 65 (2007) S39-S46.
20. 18-ceramide in HNSCC tumors correlates with lymphovascular invasion and nodal metastasis, Cancer Lett. 256 (2007) 101-111.
21. Y-Y. Liu, J.Y. Yu, D. Yin, G.A. Patwardhan, V. Gupta, Y. Hirabayashi, W.M. Holleran, A.E. Giuliano, S.M. Jazwinski, V. Gouaze-Anderson, D.P. Consoli, M.C. Cabot, A role for ceramide in driving cancer cell resistance to doxorubicin, FASEB J. Res. Commun. 22 (2008) 2541-2551. (Pubitemid 351948671)
22. L. Riboni, R. Campanella, R. Bassi, R. Villani, S.M. Gaini, F. Martinelli-Boneschi, P. Viani, G. Tettamanti, Ceramide levels are inversely associated with malignant progression of human glial tumors, Glia 39 (2002) 105-113. (Pubitemid 34817051)
23. 16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-, J. Biol. Chem. 280 (2005) 27879-27887.
24. S. Schiffmann, J. Sandner, K. Birod, I. Wobst, C. Angioni, E. Rchkhaberle, M. Kaufmann, H. Ackermann, J. Lotsch, H. Schmidt, G. Geisslinger, S. Grosch, Ceramide synthase and ceramide levels are increased in breast cancer tissue, Carcinogenesis 30 (2009) 745-752.
25. A. Penno, M.M. Reilly, H. Houlden, M. Laura, K. Rentsch, V. Niederkofler, E.T. Stoeckli, G. Nicholson, F. Eichler, R.H. Brown Jr., A. von Eckardstein, T. Hornemann, Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids, J. Biol. Chem. 285 (2010) 11178-11187.
26. 1 causes accumulation of 1-deoxysphinganine, J. Biol. Chem. 284 (2009) 4786-4795.
27. M. Bertea, M.F. Rutti, A. Othman, J. Marti-Jaun, M. Hersberger, A. von Eckardstein, T. Hornemann, Deoxysphingoid bases as plasma markers in diabetes mellitus, Lipids Health Dis. 9 (2010) 84.
28. G. van Echten-Deckert, Sphingolipid extraction and analysis by thin-layer chromatography, Methods Enzymol. 312 (2000) 64-79.
29. M. Ponec, A. Weerheim, Retinoids and lipid changes in keratinocytes, Methods Enzymol. 190 (1990) 30-41.
30. K.Y. Tserng, R. Griffin, Quantitation and molecular species determination of diacylglycerols, phosphatidylcholines, ceramides, and sphingomyelins with gas chromatography, Anal. Biochem. 323 (2003) 84-93. (Pubitemid 37393361)
31. B.J. Pettus, B-J. Kroesen, Z.M. Szulc, A. Bielawska, J. Bielawski, Y.A. Hannun, M. Busman, Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry, Rapid Commun. Mass Spectrom. 18 (2004) 577-583. (Pubitemid 38297773)
32. A.H. Merrill Jr., M.C. Sullards, J.C. Allegood, S. Kelly, E.Wang, Sphingolipidomics: high-throughput, structure-specific, andquantitative analysis of sphingolipids by liquid chromatography tandemmass spectrometry,Methods 26 (2005) 207-224. (Pubitemid 40726151)
33. M. Previati, L. Bertolaso, M. Tramarin, V. Bertagnolo, S. Capitani, Low nanogram range quantitation of diglycerides and ceramide by high-performance liquid chromatography, Anal. Biochem. 233 (1996) 108-114.
34. H. Farwanah, J. Wirtz, T. Kolter, K. Raith, R.H.H. Neubert, K. Sandhoff, Normal phase liquid chromatography coupled to quadrupole time of flight atmospheric pressure chemical ionization mass spectrometry for separation, detection, and mass spectrometric profiling of neutral sphingolipids and cholesterol, J. Chromatogr. B 877 (2009) 2976-2982.
35. H. Fawanah, T. Kolter, K. Sandhoff, Mass spectrometric analysis of neutral sphingolipids: methods, applications and limitations, Biochim. Biophys. Acta (2011) 1-7.
36. T. Kasumov, H. Huang, Y-M. Chung, R. Zhang, A. McCullough, J.P. Kirwan, Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry, Anal. Biochem. 401 (2010) 154-161.
37. R.L. Shaner, J.C. Allegood, H. Park, E. Wang, S. Kelly, C.A. Haynes, M.C. Sullards, A.H. Merrill Jr., Quantitative analysis of sphingolipids for lipidomics using triple quadrupole linear ion trap mass spectrometers, J. Lipid Res. 50 (2009) 1692-1706.
38. J. Bielawski, Z.M. Szulc, Y.A. Hannun, A. Bielawska, Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry, Methods 39 (2006) 82-91. (Pubitemid 44107706)
39. H.H. Yoo, J. Son, D-H. Kim, Liquid chromatography-tandem mass spectrometric determination of ceramides and related lipid species in cellular extracts, J. Chromatogr. B 843 (2006) 327-333. (Pubitemid 44740534)
40. T.D. Mullen, S. Spassieva, R.W. Jenkins, K. Kitatani, J. Bielawski, Y.A. Hannun, L.M. Obeid, Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism, J. Lipid Res. 52 (2011) 68-77.
41. A. McKillop, R.J.K. Taylor, R.J. Watson, N. Lewis, An improved procedure for the preparation of the Garner aldehyde and its use for the synthesis of N-protected 1-halo-2-(R)-amino-3-butenes, Synthesis (1994) 31-33. (Pubitemid 24082763)
42. A. Dondoni, D. Perrone, Synthesis of N-(tert-butoxycarbonyl)-N, O-isopropylidene serinal from serine methyl ester by a reduction-oxidation sequence, Synthesis (1997) 527-529. (Pubitemid 27244939)
43. P. Herold, Synthesis of D-erythro- and D-threo-sphingosine derivatives from L-serine, Helv. Chim. Acta 71 (1988) 354-362. (Pubitemid 18065129)
44. C. Curfman, D. Liotta, Synthesis of sphingosine and sphingoid bases, Methods Enzymol. 311 (1999) 391-440. (Pubitemid 29512782)
45. S.M. Hammad, J.S. Pierce, F. Soodavar, K.J. Smith, M.M. Al Gadban, B. Rembiesa, R.L. Klein, Y.A. Hannun, J. Bielawski, A. Bielawska, Blood sphingolipidomics in healthy humans: impact of sample collection methodology, J. Lipid Res. 51 (2010) 3074-3086.
46. M.C. Sullards, A.H. Merrill Jr., Analysis of sphingosine-1-phosphate, ceramides, and other bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry, Sci. STKE (2001), doi:10.1126/stke. 2001.67.pl1.
47. J.C. Miller, J.N. Miller, Statistics for Analytical Chemistry, third ed., Ellis Horwood, Chichester, UK, 1992.
48. W. Drobnik, G. Liebisch, F.X. Audebert, D. Frohlich, T. Gluck, P. Vogel, G. Rothe, G. Schmitz, Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients, J. Lipid Res. 44 (2003) 754-761. (Pubitemid 37279677)
49. K. Samuelsson, Identification and quantitative determination of ceramides in human plasma, Scand. J. Clin. Lab. Invest. 27 (1971) 371-380.
50. J.E.M. Groener, B.J.H.M. Poorthuis, S. Kuiper, M.T.J. Helmond, C.E.M. Hollak, J.M.F.G. Aerts, HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma, Clin. Chem. 53 (2007) 742-747. (Pubitemid 46580247)
51. E.J. Jeyarajah, W.C. Cromwell, J.D. Otvos, Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy, Clin. Lab. Med. 26 (2006) 847-870. (Pubitemid 44716510)
52. M.R. Soeters, H.P. Sauerwein, J.E. Groener, J.M. Aerts, M.T. Ackermans, J.F.C. Glatz, E. Fliers, M.J. Serlie, Gender-related differences in the metabolic response to fasting, J. Clin. Endocrinol. Metab. 92 (2007) 3646-3652. (Pubitemid 47435351)